Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GN.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.8.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.10.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.89SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HP.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GW.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GS.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XCF.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JC.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.105SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.9.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.103SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HC.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FE.1.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.94SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.15.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.213SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.341SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.89SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.204SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.50SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.170SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.232SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.84SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.76SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.301SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.269SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.234SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Z.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
V.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.282SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.274SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.65SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.165SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.528SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.91 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used